N2OFF, Inc. has announced a special meeting of its stockholders to be held on September 25, 2025. The meeting will take place at the offices of the company's Israel legal counsel, Meitar | Law Offices, in Ramat Gan, Israel. During the meeting, stockholders will be asked to consider and vote on a proposal to approve the acquisition of all share capital of MitoCareX Bio Ltd., a private company incorporated under the laws.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.